Cargando…
Prioritization of Molecular Targets for Antimalarial Drug Discovery
[Image: see text] There is a shift in antimalarial drug discovery from phenotypic screening toward target-based approaches, as more potential drug targets are being validated in Plasmodium species. Given the high attrition rate and high cost of drug discovery, it is important to select the targets m...
Autores principales: | Forte, Barbara, Ottilie, Sabine, Plater, Andrew, Campo, Brice, Dechering, Koen J., Gamo, Francisco Javier, Goldberg, Daniel E., Istvan, Eva S., Lee, Marcus, Lukens, Amanda K., McNamara, Case W., Niles, Jacquin C., Okombo, John, Pasaje, Charisse Flerida A., Siegel, Miles G., Wirth, Dyann, Wyllie, Susan, Fidock, David A., Baragaña, Beatriz, Winzeler, Elizabeth A., Gilbert, Ian H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608365/ https://www.ncbi.nlm.nih.gov/pubmed/34523908 http://dx.doi.org/10.1021/acsinfecdis.1c00322 |
Ejemplares similares
-
MalDA, Accelerating Malaria Drug Discovery
por: Yang, Tuo, et al.
Publicado: (2021) -
The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance
por: Murithi, James M., et al.
Publicado: (2022) -
Phosphatidylinositol 3-phosphate and Hsp70 protect Plasmodium falciparum from heat-induced cell death
por: Lu, Kuan-Yi, et al.
Publicado: (2020) -
Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention
por: Summers, Robert L., et al.
Publicado: (2022) -
Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formation
por: Bopp, Selina, et al.
Publicado: (2023)